Galapagos Quote - GXE

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

22.60

Bid

22.52

Ask

22.68

Volume

1,097

22.40 Day's Range 22.74

21.80 52 Week Range 37.08

Market Cap

1.488B

Previous Close

22.80

Open

22.40

Last Trade

22.66

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

7,901

Shares Outstanding

65,835,511

Dividend Yield

PE Ratio

7.06

Earnings Per Share (EPS)

3.22

Revenue

843.8M

Net Profit

211.7M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.glpg.com

Headquarters

Mechelen, Antwerp, Bel

Founded

Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Tradegate (DE) with ticker GXE. The last closing price for Galapagos was 22.80 €. Over the last year, Galapagos shares have traded in a share price range of 21.80 € to 37.08 €.

Galapagos currently has 65,835,511 shares outstanding. The market capitalization of Galapagos is 1.50 € billion. Galapagos has a price to earnings ratio (PE ratio) of 7.06.

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos intends to create a new company with approximately €2.45 billion in cash...

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Company...

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma Data from the ongoing Phase...

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma

Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma Mechelen, Belgium; August 23, 2024, 07:00...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.72	-3.08747855918	23.32	23.38	22.22	3036	22.95251993	DE
4	-2.98	-11.6497263487	25.58	30.96	22.22	3684	25.39378246	DE
12	-1.78	-7.30106644791	24.38	30.96	22.22	7901	25.27946651	DE
26	-2.22	-8.94439967768	24.82	30.96	21.8	9438	25.07386805	DE
52	-12.61	-35.8136892928	35.21	37.08	21.8	8849	26.55851179	DE
156	-27.2	-54.6184738956	49.8	66.4	21.8	4445	27.37065642	DE
260	-156.35	-87.3707739592	178.95	189.3	21.8	2675	28.58687287	DE

GXE - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?

The current share price of Galapagos is 22.60 €

How many Galapagos shares are in issue?

Galapagos has 65,835,511 shares in issue

What is the market cap of Galapagos?

The market capitalisation of Galapagos is EUR 1.5B

What is the 1 year trading range for Galapagos share price?

Galapagos has traded in the range of 21.80 € to 37.08 € during the past year

What is the PE ratio of Galapagos?

The price to earnings ratio of Galapagos is 7.06

What is the cash to sales ratio of Galapagos?

The cash to sales ratio of Galapagos is 1.77

What is the reporting currency for Galapagos?

Galapagos reports financial results in EUR

What is the latest annual turnover for Galapagos?

The latest annual turnover of Galapagos is EUR 843.8M

What is the latest annual profit for Galapagos?

The latest annual profit of Galapagos is EUR 211.7M

What is the registered address of Galapagos?

The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800

What is the Galapagos website address?

The website address for Galapagos is www.glpg.com

Which industry sector does Galapagos operate in?

Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LL3PanGenomic Health Inc	0.2999 € (67.26%)	2.89k
VAR1Varta AG	1.00 € (37.93%)	3.62M
FP9Five Point Holdings LLC	5.35 € (36.48%)	20
UD9Mason Resources Inc	0.0616 € (36.28%)	28k
8CTCannabix Technologies Inc	0.32 € (33.33%)	250
E3TMetavista 3D Inc	1.49 € (-50.99%)	5.26M
E3O1Nexoptic Technology Corp	0.008 € (-48.39%)	34.02k
POTAPortofino Resources Inc	0.0032 € (-38.46%)	150k
G12Global Atomic Corp	0.425 € (-31.95%)	729.18k
1UR1Bee Vectoring Technologies International Inc	0.0035 € (-30.00%)	139.6k
PF8European Lithium Limited	0.0348 € (-3.33%)	9.79M
E3TMetavista 3D Inc	1.49 € (-50.99%)	5.26M
D7GNel ASA	0.1932 € (0.99%)	4.13M
0QJHexagon Purus ASA	0.2725 € (-22.59%)	3.99M
VAR1Varta AG	1.00 € (37.93%)	3.62M